Comparative efficacy and tolerability of targeted and immunotherapy combined with chemotherapy as first-line treatment for advanced gastric cancer: a Bayesian network meta-analysis.

Sci Rep · 2022 · PMC9768117 · PMID 36539429

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

very close to statistical significanceno p-value reported

No regimen showed an obviously improvement than standard chemotherapy, although nivolumab was very close to statistical significance (HR 0.73, 95% CI 0.5–1.06).

also in 143 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.